Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin

Toxicology and Applied Pharmacology

Volumn 140, Issue 1, 1996, Pages 85-93

  Crooke, Rosanne M ^a   Crooke, Stanley T ^a   Graham, Mark J ^a   Cooke, Margaret E ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFOVIRSEN; ANTISENSE OLIGONUCLEOTIDE; CAPSID PROTEIN; INTERLEUKIN 1ALPHA; VIRUS PROTEIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOCHEMISTRY; EPIDERMIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; KERATINOCYTE; MODEL; SKIN; SKIN FIBROBLAST;

HERPES; HUMAN HERPESVIRUS 1; MIRIDAE;

EID: 0030245626     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0200     Document Type: Article

References (38)

1. Ansel, J., Perry, P., Brown, J., Damm, D., Phan, T., Hart, C., Luger, T., and Hefeneider, S. (1990). Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 94, 101S-107S.
2. Barker, J. N. W. N., Mitra, R. S., Griffiths, C. E. M., Dixit, V. M., and Nickoloff, B. J. (1991). Keratinocytes as initiators of inflammation. Lancet 337, 211-214.
3. Chiang, M.-Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., and Bennett, C. F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
4. Colby, C. (1971). The induction of Interferon by natural and synthetic polynucleotides. In Progress in Nucleic Acid Research and Molecular Biology (T. N. Davidson and W. E. Cohn, Eds.), pp. 1-32. Springer-Verlag, New York, NY.
5. Cornish, K. G., Iversen, P., Smith, L., Arneson, M., and Bayever, E. (1993). Cardiovascular effects of a phosphorothioate oligonucleotide with sequence antisense to p53 in the conscious Rhesus monkey. Pharmacol. Commun. 3, 239-247.
6. Crooke, R. M. (1993). In vitro and in vivo toxicology of first generation analogs. In Antisense Research and Applications (S. T. Crooke and B. LeBleu, Eds.), pp. 471-492. CRC Press, Boca Raton, FL.
7. Crooke, R. M., Graham, M. J., Cooke, Margaret E., and Crooke, S. T. (1995). In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J. Pharm. Exp. Ther. 275, 462-473.
8. Crooke, R. M., Hoke, G. D., and Shoemaker, J. E. (1992). In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of Herpes Simplex Virus. Antimicrob. Agents Chemother. 36, 527-532.
9. Crooke, S. T. (1992). Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32, 329-376.
10. Crooke, S. T. (1995). Therapeutic Applications of Oligonucleotides. R. G. Landes, Austin, TX.
11. 14C-labeled afovirsen sodium in genital wart patients. Clin. Pharm. Ther. 56, 641-646.
12. Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., Sasmor, H. M., Schleich, T., Tivel, K. L., and Griffey, R. H. (1996). Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharm. Exp. Ther., 277, 923-937.
13. Cummins, L. L., Owens, S. R., Risen, L. M., Lesnik, E. A., Freier, S. M., McGee, D., Guinosso, C. J., and Cook, P. D. (1995). Characterization of fully 2′ modified oligoribonucleotide hetero-and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res. 23, 2019-2024.
14. Dinarello, C. A. (1992). The biology of interleukin-1. In Interleukins: Molecular Biology and Immunology. Chem. Immunol. (T. Kishimoto, Ed.), Vol. 52, pp. 1-32. Karger, Basel.
15. Draper, K. G., and Brown-Driver, V. (1991). Reduction of herpes simplex virus infection using phosphorothioate oligonucleotides complementary to viral mRNA. Antiviral Res. (Suppl. 1), 106.
16. Hijiya, N., Zhang, J., Ratajczak, M., Kant, J. A., DeRiel, K., Herlyn, M., Zon, G., and Gewirtz, A. M. (1994). Biologic and therapeutic significance of MYB expression in human melanoma. Proc. Natl. Acad. Sci. USA 91, 4499-4503.
17. Kawasaki, A. M., Casper, M. D., Freier, S. M., Lesnik, E. A., Zounes, M. A., Cummins, L. L., Gonzalez, C., and Cook, P. D. (1993). Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J. Med. Chem. 36, 831-841.
18. Krieg, A. M., Yi, A-E., Matson, S., Waldschmidt, T. J., Bishops, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. (1995). GpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
19. Kupper, T. S., Chua, A. O., Flood, P., McGuire, J., and Gubler, U. (1987). Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J. Clin. Invest. 80, 430-436.
20. Lee, S. W., Morhenn, V. B., Ilnicka, M., Eugui, E. M., and Allison, A. C. (1991). Autocrine stimulation of interleukin-1α and transforming growth factor α production in human keratinocytes and its antagonism by glucocorticoids. J. Invest. Dermatol. 96, 106-110.
21. Luger, T. A., and Schwarz, T. (1990). Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95, 100S-104S.
22. McKenzie, R. C., and Sauder, D. N. (1990). The role of keratinocyte cytokines in inflammation and immunity. J. Invest. Dermatol. 95, 105S-107S.
23. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., and Freier, S. M. (1993). Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522.
24. Muller-Decker, K., Furstenberger, G., and Marks, F. (1994). Keratinocyte-derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: A possible alternative to the Draize skin irritation test. Toxicol. Appl. Pharmacol. 127, 99-108.
25. Nagami, K., and Maki, E. (1993). In vitro cytotoxicity test for estimating non-ocular irritation dose of opthalmic solutions. Cell Biol. Tox. 9, 107-118.
26. Nickoloff, B. J., and Turka, L. A. (1993). Keratinocytes: Key immunocytes of the integument. Am. J. Pathol. 143, 325-331.
27. Nozaki, S., Feliciani, C., and Sauder, D. N. (1991). Keratinocyte cytokines. Adv. Dermatol. 7, 83-101.
28. Offensperger, W.-B., Offensperger, S., Walter, E., Teubner, K., Igloi, G., Blum, H. E., and Gerok, W. (1993). In vivo inhibition of duck hepatitis B replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J. 12, 1257-1262.
29. Partridge, M., Chantry, M., Turnerm, M., and Feldmann, M. (1991). Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J. Invest. Dermatol. 96, 771-776.
30. Sarmiento, U. M., Perez, J. R., Becker, J. M., and Narayanan, R. (1994). In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res. Dev. 4, 99-107.
31. Skorski, T., Nieborowska-Skorska, M., Nicolaides, N. C., Szezylik, C., Iversen, P., Iozzo, R. V., Zon, G., and Calabretta, B. (1994). Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 91, 4504-4508.
32. Slivka, S. R., Landeen, L. K., Ziegler, F., Zimber, M. P., and Bartel, R. L. (1993). Characterization, barrier function and drug metabolism of an in vitro skin model. J. Invest. Dermatol. 100, 40-46.
33. Stein, C. A., and Cheng, Y.-C. (1993). Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 261, 1004-1012.
34. Stepkowski, S. M., Tu, Y., Condon, T. P., and Bennett, C. F. (1994). Blocking of heart allograft rejection by intercellular adhesion molecule-antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol. 153, 5336-5346.
35. Storey, A., Oates, D., Banks, L., Crawford, L., and Crook, T. (1991). Anti-sense phosphorothioate oligonucleotides have both specific and nonspecific effects on cells containing human papillomavirus type 16. Nucleic Acids Res. 19, 4109-4114.
36. Triglia, D., Braa, S. S., Yonan, C., and Naughton, G. K. (1991). Cytotoxicity testing using neutral red and MTT assays on a three-dimensional human skin substrate. Tox. In Vitro 5, 573-578.
37. Whitesell, L., Rosolen, A., and Neckers, L. M. (1991). In vivo modulation of N-myc expression by continuous perfusion with an antisense oligonucleotide. Antisense Res. Dev. 1, 343-350.
38. Wyatt, J. R., Vickers, T. A., Roberson, J. L., Buckheit, R. W., Jr., Klimkait, T., DeBaets, E., Davis, P. W., Rayner, B., Imbach, J. L., and Ecker, D. J. (1994). Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA 91, 1356-1360.